DE69705569T2 - Impfpackung enthaltend ein Behälter mit gefriertrockenen Impfkomponenten - Google Patents

Impfpackung enthaltend ein Behälter mit gefriertrockenen Impfkomponenten

Info

Publication number
DE69705569T2
DE69705569T2 DE69705569T DE69705569T DE69705569T2 DE 69705569 T2 DE69705569 T2 DE 69705569T2 DE 69705569 T DE69705569 T DE 69705569T DE 69705569 T DE69705569 T DE 69705569T DE 69705569 T2 DE69705569 T2 DE 69705569T2
Authority
DE
Germany
Prior art keywords
vaccine
container
freeze
dried
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69705569T
Other languages
English (en)
Other versions
DE69705569D1 (de
Inventor
Antonius Theodorus Wilderbeek
Hans Almer Middelbeek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE69705569D1 publication Critical patent/DE69705569D1/de
Application granted granted Critical
Publication of DE69705569T2 publication Critical patent/DE69705569T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)
DE69705569T 1996-03-07 1997-03-05 Impfpackung enthaltend ein Behälter mit gefriertrockenen Impfkomponenten Expired - Lifetime DE69705569T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96200621 1996-03-07

Publications (2)

Publication Number Publication Date
DE69705569D1 DE69705569D1 (de) 2001-08-16
DE69705569T2 true DE69705569T2 (de) 2002-05-16

Family

ID=8223754

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69705569T Expired - Lifetime DE69705569T2 (de) 1996-03-07 1997-03-05 Impfpackung enthaltend ein Behälter mit gefriertrockenen Impfkomponenten

Country Status (19)

Country Link
US (2) US5897852A (de)
EP (1) EP0799613B1 (de)
JP (1) JP4293643B2 (de)
KR (1) KR100458370B1 (de)
CN (1) CN1133423C (de)
AT (1) ATE202925T1 (de)
AU (1) AU704629B2 (de)
CA (1) CA2198195C (de)
DE (1) DE69705569T2 (de)
DK (1) DK0799613T3 (de)
EG (1) EG23992A (de)
ES (1) ES2161412T3 (de)
GR (1) GR3036725T3 (de)
HU (1) HU220532B1 (de)
IL (1) IL120202A (de)
NZ (1) NZ314267A (de)
PT (1) PT799613E (de)
SA (1) SA97170715B1 (de)
ZA (1) ZA971734B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
CA2382652A1 (en) * 1999-08-24 2001-03-01 Teva Pharmaceutical Industries, Ltd. A vaccine composition and method of using the same
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
AUPR750501A0 (en) * 2001-09-05 2001-09-27 Gauci, Mark Products comprising quantum of bioparticles and method for production thereof
US6780581B2 (en) 2001-09-12 2004-08-24 Btf Pty Ltd Products comprising quantum of bioparticles and method for production thereof
RU2006126051A (ru) * 2003-12-19 2008-01-27 Альк-Абелло А/С (Dk) Способы получения партии активного фармацевтического ингредиента, контейнер, содержащий криогранулы аллергенного продукта, и криогранула аллергенного продукта
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
TWI436789B (zh) * 2008-01-21 2014-05-11 Intervet Int Bv 含有藥學化合物的顆粒之冷凍乾燥方法及含有此顆粒的藥學包
TWI444384B (zh) * 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
WO2009109550A1 (en) 2008-03-05 2009-09-11 Sanofi Pasteur Process for stabilizing an adjuvant containing vaccine composition
EP2143440A1 (de) 2008-07-09 2010-01-13 Sanofi Pasteur Stabilisierungssubstanz und Impfzusammensetzung, die ein oder mehrere abgeschwächte lebende Flaviviridae enthält
TW201043267A (en) * 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
JP5980810B2 (ja) 2010-12-29 2016-09-07 インターベット インターナショナル ベー． フェー． イヌバベシア症ワクチン抗原
AU2012306282A1 (en) 2011-09-08 2014-03-20 Umc Utrecht Holding B.V. Vaccine based on Staphylococcal superantigen-like 3 protein (SSL3)
JP2014533240A (ja) 2011-10-31 2014-12-11 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 生物材料の凍結乾燥球形ペレットを調製する方法
US10617650B2 (en) * 2015-10-16 2020-04-14 Merck Sharp & Dohme Corp. Process for preparing formulations for gastrointestinal-targeted therapies
NL2018155B1 (en) 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
CN113862332A (zh) * 2021-09-17 2021-12-31 浙江大学 琼脂糖在制备生物大分子冻干保护剂中的应用
CN114159555A (zh) * 2021-12-08 2022-03-11 江西赛基生物技术有限公司 抗原蛋白冻干小球及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655838A (en) * 1969-03-20 1972-04-11 Organon Method of pelletizing analytical or immunological reagents
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
DE2243014C2 (de) * 1971-09-03 1986-05-28 E.I. Du Pont De Nemours And Co., Wilmington, Del. Verfahren zur Herstellung eines homogenen, gefriergetrockneten Serum- oder Plasmaproduktes
US3857423A (en) * 1971-12-27 1974-12-31 W Ronca Topical medicament kit with interlocking components
US3893280A (en) * 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
US4351158A (en) * 1980-01-22 1982-09-28 American Home Products Corporation Method of producing multicomponent lyophilized product
US4295280A (en) * 1980-03-17 1981-10-20 American Home Products Corporation Method of obtaining a lyophilized product
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
IL86180A (en) 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines
AT390192B (de) * 1988-08-29 1990-03-26 Immuno Ag Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
US5044091B1 (en) * 1989-04-18 1997-12-30 Sankyo Co Method of preparing a freeze-dried formulation of a drug
DE69005800T2 (de) * 1989-05-01 1994-05-19 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekülen.
IE64738B1 (en) 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
AU650045B2 (en) * 1990-09-12 1994-06-09 Lifecell Corporation Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions
NZ265956A (en) * 1993-04-28 1996-09-25 Akzo Nobel Nv Lyospheres containing gonadotropin and compositions thereof
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components

Also Published As

Publication number Publication date
HUP9700556A2 (en) 1997-12-29
AU704629B2 (en) 1999-04-29
CA2198195C (en) 2005-10-25
EP0799613A1 (de) 1997-10-08
AU1514997A (en) 1997-09-11
IL120202A (en) 2001-03-19
SA97170715B1 (ar) 2006-10-11
HU220532B1 (hu) 2002-03-28
GR3036725T3 (en) 2001-12-31
US5897852A (en) 1999-04-27
ATE202925T1 (de) 2001-07-15
KR970064584A (ko) 1997-10-13
ES2161412T3 (es) 2001-12-01
JPH1024090A (ja) 1998-01-27
DE69705569D1 (de) 2001-08-16
HUP9700556A3 (en) 2000-04-28
CN1133423C (zh) 2004-01-07
JP4293643B2 (ja) 2009-07-08
NZ314267A (en) 1998-01-26
HU9700556D0 (en) 1997-04-28
CN1163102A (zh) 1997-10-29
IL120202A0 (en) 1997-06-10
ZA971734B (en) 1997-09-09
US6106836A (en) 2000-08-22
EG23992A (en) 2008-03-09
MX9701726A (es) 1998-03-31
KR100458370B1 (ko) 2005-07-07
CA2198195A1 (en) 1997-09-07
EP0799613B1 (de) 2001-07-11
PT799613E (pt) 2001-12-28
DK0799613T3 (da) 2001-10-22

Similar Documents

Publication Publication Date Title
DE69705569D1 (de) Impfpackung enthaltend ein Behälter mit gefriertrockenen Impfkomponenten
DE68903985D1 (de) Behaelter fuer den transport von transplantaten.
DK164479C (da) Sucralfatsuspension og fremgangsmaade til fremstilling af denne
DK570088D0 (da) Pulvertaet genlukkeligt laag til emballager
EP0599532A3 (de) Härtbare Einkomponenten-Organosiloxanzusammensetzungen.
NO910731D0 (no) Fremgangsmaate for fremstilling av 2-r2-r4-substituert-3-r3-co-1-((c-tilknyttet-n-heteryl)-(alk)n)-1h-indoler.
DE69103699D1 (de) Kasten zur Aufnahme von Flaschen.
DE3889320D1 (de) Härtbare Organopolysiloxanzusammensetzung.
MX9201950A (es) Composiciones de bronceado artificial que contienen vesiculas paucilaminares positivamente cargadas.
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
DE59409434D1 (de) Verfahren zur Herstellung von Hydroxyphenyl-1,3,5-Triazinen
DE3769547D1 (de) Bauteilsatz aus abschliessbaren boxen zur herstellung von einstellraeumen fuer zweiraeder.
IL64292A (en) D-homoandrostane-17alpha-carboxylic acids,derivatives thereof and 17alpha-spiroethers,their manufacture and pharmaceutical compositions containing them
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
DE59402292D1 (de) Verfahren zur Herstellung von 1,3,5-Triazinen
DE69300551D1 (de) Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid.
DE69425028D1 (de) Zusammensetzung zur Konservierung von Holzprodukten
IL84325A0 (en) Device for finding words or terms in books,such as dictionaries
DE69320454T2 (de) Verfahren zur Herstellung von 1,3-butylenglykol
DE68911603D1 (de) Verfahren zur Herstellung von 2-Pyrrolidon.
FR2624831B1 (fr) Caisse de conditionnement composite repliable
DE69410222D1 (de) Verfahren zur Herstellung von optisch aktiven Erythro-3-amino-1,2-epoxy-Verbindungen
FR2626250B1 (fr) Emballage de carton ou analogue, en forme de plateau
DE3888543D1 (de) Zusammensetzungen zur herstellung von gasdurchlässigen kontaktlinsen.
DE59405085D1 (de) Verfahren zur Herstellung von Tetrachlor-1,4-benzochinon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTERVET INTERNATIONAL B. V., AN BOXMEER, NL